StemSep
Navigation Links
StemSep at biology products
StemSep Hu-Mu Chimera Starter Kit, Kit from StemCell Technologies, Inc.
Description:This complete kit contains enough separation reagents to perform separations from a total of 5 x 10 cells, and includes the StemSep red magnet and all the necessary reagents and buffers for the specific cell type to be enriched, including the StemSep red magnet....Company:StemCell Technologies, Inc.
StemSep CD45RA Tetramer, 100 uL from StemCell Technologies, Inc.
Description:When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD45RA TAC is designed to deplete human CD45RA from samples to isolate memory CD4+ or CD8+ T cells....Company:StemCell Technologies, Inc.
StemSep Anti-Human CD69 Tetramer, 200 uL from StemCell Technologies, Inc.
Description:When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD69 TAC is designed to deplete human CD69 from samples to isolate resting CD4+ or CD8+ T cells....Company:StemCell Technologies, Inc.
StemSep anti-Hu TCR alpha beta, 200 uL from StemCell Technologies, Inc.
Description:When added to StemSep T Cell Enrichment cocktail, human TCRab TAC is designed to deplete human TCRab from samples to isolate gd T cells....Company:StemCell Technologies, Inc.
StemSep Anti-Hu HLA-DR Tetramer, 100 uL from StemCell Technologies, Inc.
Description:When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human HLA-DR TAC is designed to deplete human HLA-DR from samples to isolate resting CD4+ or CD8+ T cells....Company:StemCell Technologies, Inc.
StemSep Anti-Hu HLA-DR Tetramer, 200 uL from StemCell Technologies, Inc.
Description:When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human HLA-DR TAC is designed to deplete human HLA-DR from samples to isolate resting CD4+ or CD8+ T cells....Company:StemCell Technologies, Inc.
StemSep Rat CD4+ T Cells, 10 mL from StemCell Technologies, Inc.
Description:This depletion cocktail is tailored to highly enrich CD4+ T cells from suspensions of rat spleen cells. Cells are separated using the StemSep (or compatible 0.5 Tesla) immunomagnetic negative cell selection system. The CD4+ T cell content of the enriched fraction typically ranges from 93 to 99%....Company:StemCell Technologies, Inc.
StemSep Rhesus CD4+ T Cells, 2 mL Kit from StemCell Technologies, Inc.
Description:This depletion cocktail is tailored to highly enrich CD4+ T cells from suspensions of non-human primate (Rhesus monkey) cells. Cells are separated using the StemSep compatible 0.5 Tesla) immunomagnetic negative selection system. The CD4+ T cell content of the enriched fraction typically ranges from 93 to 99%....Company:StemCell Technologies, Inc.
StemSep Rhesus T Cell Purging, 2 mL Kit from StemCell Technologies, Inc.
Description:This depletion cocktail is tailored to efficiently deplete T (CD3+CD4+CD8+) cells from suspensions of non-human primate (Rhesus monkey) cells. Cells are separated using the StemSep (or compatible 0.5 Tesla) immunomagnetic negative selection system, achieving a 2.6 Log depletion of T cells....Company:StemCell Technologies, Inc.
StemSep Rat T Cells, 2 mL from StemCell Technologies, Inc.
Description:This depletion cocktail is tailored to highly enrich T cells from suspensions of rat spleen cells. Cells are separated using the StemSep (or compatible 0.5 Tesla) immunomagnetic negative selection system. The T cell content of the enriched fraction typically ranges from 98 to 99%....Company:StemCell Technologies, Inc.
StemSep Anti-Phycoertherin TAC, 2 mL from StemCell Technologies, Inc.
Description:StemSep Anti-Phycoertherin Tetrameric Antibody Complexes, 2 mL for labeling 1x10 cells. Cross-linking Reagent for StemSep Separations of Cells Labeled with PE-conjugated Antibody....Company:StemCell Technologies, Inc.
Other TagsTABTABTABTABTABTABTABTABTABReFORMReFORMReFORMOther Contentspumppumppumppumppumppumppumppumppumpprotonprotonprotonprotonprotonprotonprotozoaprotozoaprotozoaprotozoaprotozoapseudopodpurineequilibriumequilibriumequilibriumequilibriumequilibriumequilibriumpunctuatedpunctuatedpyrimidine
DatexCardiocapDeltatracAnesthetistsCapnomacPrecordialTABThermocoupleReFORMNeurolasSmartLipoSmartChillSmartCryoSmartPulse
(Date:10/10/2008)...n a previously unknown relationship between stem c...ondria a cell,s energy makers. Stem cells with mor... to differentiate and are more likely to form tumo...C, could lead to methods of enriching the best ste...may provide some insights into the role of stem ce...
(Date:10/10/2008)...E, MADISON Governor Jim Doyle today announced a h...rch institutions to advance personalized health ca...es diseases. The Wisconsin Genomics Initiative is ...ld Clinic, Medical College of Wisconsin (MCW), Uni... Health (UWSMPH) and UW-Milwaukee (UWM). , Wisco...
(Date:10/10/2008)...ng the 1950s, Austrian and Swiss scientists conduc...al taking photographs of the glaciers, mountains a...logist Fritz Mller spent eight months in the regio...tographing the Himalayan glaciers. , Now, fifty ... by these scientists are of immense value in tryin...
(Date:10/10/2008)...able in German . , DNA, the molecule that act...ms of life, is highly resistant against alteration...nism for its photostability presents some puzzling... the four chemical bases that make up the DNA mole...d in showing that DNA strands differ in their ligh...
Breaking Biology News(10 mins):Governor Doyle announces historic genomic research collaboration 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3Can genetic information be controlled by light? 2At Annual and Special Meeting of Shareholders Neurochem to officially adopt new name BELLUS Health And to provide update on programs including f 16805 1At Annual and Special Meeting of Shareholders Neurochem to officially adopt new name BELLUS Health And to provide update on programs including f 16805 2At Annual and Special Meeting of Shareholders Neurochem to officially adopt new name BELLUS Health And to provide update on programs including f 16805 3At Annual and Special Meeting of Shareholders Neurochem to officially adopt new name BELLUS Health And to provide update on programs including f 16805 4At Annual and Special Meeting of Shareholders Neurochem to officially adopt new name BELLUS Health And to provide update on programs including f 16805 5At Annual and Special Meeting of Shareholders Neurochem to officially adopt new name BELLUS Health And to provide update on programs including f 16805 6Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A NPHC PECD PNRR 4595 1Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A NPHC PECD PNRR 4595 2Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A NPHC PECD PNRR 4595 3Pharmacopeia Announces Upcoming Late Breaker Presentation of Phase 2a Results for Its First in Class Investigational DARA Compound PS433540 1786 1Pharmacopeia Announces Upcoming Late Breaker Presentation of Phase 2a Results for Its First in Class Investigational DARA Compound PS433540 1786 2Pharmacopeia Announces Upcoming Late Breaker Presentation of Phase 2a Results for Its First in Class Investigational DARA Compound PS433540 1786 3Pharmacopeia Announces Upcoming Late Breaker Presentation of Phase 2a Results for Its First in Class Investigational DARA Compound PS433540 1786 4Heritage Announces 2410 Million Financing 16801 1Heritage Announces 2410 Million Financing 16801 2(Date:10/10/2008)...uView Life Sciences Inc.,(NuView) has agreed to as...), including operations of the linear accelerator ...as. The Trace facility produces,Copper-64, Copper-...in,molecular imaging and nuclear medicine. Paul Cr...confident that by improving operational,efficienci...
(Date:10/10/2008)...ire/ -- Public interest,advocates(1) welcomed the ...ions on the threats posed by mercury to human heal...UNEP(2) Open Ended Working Group (OEWG2) on,Mercur... global framework,on mercury, in preparation for t...here it will be decided whether a global legally-b...
(Date:10/10/2008)...-term side effects, study finds , , FRI...y alone, and delaying or avoiding radiation altoge...noperable or progressive low-grade glioma brain tu..., Low-grade glioma is the most common brain tumor...vival rate for patients is 95 percent. But prognos...
(Date:10/10/2008)...in the implementation of electronic health records... Systems Society (HIMSS) announces the recipients ...mbulatory and Community Health Organization catego...B) October 10, 2008 -- Honoring excellence in the ..., the Healthcare Information and Management Syste...
Breaking Medicine News(10 mins):Health News:Elements for a UN Global Framework on Mercury Agreed to 2Health News:Chemo Alone Effective in Treating Kids' Brain Tumors 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5[0] NuView Life Sciences Inc. Assumes Management of Trace Life Sciences Inc. Radioisotope Production Facility[0] Elements for a UN Global Framework on Mercury Agreed to[0] Chemo Alone Effective in Treating Kids' Brain Tumors[0] 2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized
| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |